- Home
- BZH vs KURA Comparison
BZH vs KURA Comparison
Compare BZH & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BZH
- KURA
- Stock Information
- Founded
- BZH 1985
- KURA 2014
- Country
- BZH United States
- KURA United States
- Employees
- BZH N/A
- KURA N/A
- Industry
- BZH Homebuilding
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BZH Consumer Discretionary
- KURA Health Care
- Exchange
- BZH Nasdaq
- KURA Nasdaq
- Market Cap
- BZH 577.8M
- KURA 592.7M
- IPO Year
- BZH 1994
- KURA N/A
- Fundamental
- Price
- BZH $18.59
- KURA $5.90
- Analyst Decision
- BZH Strong Buy
- KURA Strong Buy
- Analyst Count
- BZH 3
- KURA 10
- Target Price
- BZH $39.67
- KURA $25.50
- AVG Volume (30 Days)
- BZH 418.0K
- KURA 1.6M
- Earning Date
- BZH 04-30-2025
- KURA 05-01-2025
- Dividend Yield
- BZH N/A
- KURA N/A
- EPS Growth
- BZH N/A
- KURA N/A
- EPS
- BZH 3.93
- KURA N/A
- Revenue
- BZH $2,412,332,000.00
- KURA $53,883,000.00
- Revenue This Year
- BZH $12.48
- KURA $44.32
- Revenue Next Year
- BZH $14.99
- KURA $173.73
- P/E Ratio
- BZH $4.72
- KURA N/A
- Revenue Growth
- BZH 12.27
- KURA N/A
- 52 Week Low
- BZH $17.37
- KURA $5.41
- 52 Week High
- BZH $38.22
- KURA $23.48
- Technical
- Relative Strength Index (RSI)
- BZH 40.46
- KURA 38.78
- Support Level
- BZH $17.63
- KURA $5.48
- Resistance Level
- BZH $18.87
- KURA $6.11
- Average True Range (ATR)
- BZH 1.24
- KURA 0.39
- MACD
- BZH -0.05
- KURA 0.01
- Stochastic Oscillator
- BZH 33.89
- KURA 31.82
About BZH Beazer Homes USA Inc.
Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in over 13 states and over 22 metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the leading sources of revenue for the company. Key metro areas include Atlanta, Las Vegas, Los Angeles, Orlando, and Tampa. The company also focuses on land purchasing and development to support future construction efforts as well as mortgage services for its homebuyers.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.